The evidence is balanced enough to avoid a defensive call, but not aligned enough for aggressive positioning.
52
technical evidence
out of 100
out of 100
Week Ending: 14 August 2026
Taiwan TW Healthcare Industry
Drug Manufacturers - Specialty & Generic
For the week ending 14 August 2026, Drug Manufacturers - Specialty & Generic advanced 0.48% with 5 advancing, 8 declining, and 0 unchanged constituents. The index is equal weighted and the constituent tape shows uncapped security returns.
Current architecture
Balance
Directional pressure is compressed and neither side has durable control.
52
technical evidence
Index2097.19
1 week0.48%
Breadth38%
Members13
Country
🇹🇼 Taiwan · TW
Sector
Healthcare
Universe
country-listed
Price basis
Adjusted weekly close
Trend architecture
Index, activity fan and structural anchors
Rolling 156-week evidence. Trend Signal points mark weeks when price, trend and the activity fan confirmed together.
Index Value
Trend Line
Fair Value
Activity Lines
Constructive architecture
Transitional architecture
Defensive architecture
Current architecture
Balance
4 completed weeks in this state
Trend acceptance
0.9%
Index versus Trend Line
Persistence
75%
Positive regime, horizons divided
Participation
38%
5 advancing, 8 declining
Investor positioning lens
Is the evidence ready for capital?
A rules-based technical classification using trend, breadth, persistence, relative strength and path quality.
Evidence balance
Wait
Five-pillar map
Trend
51
Breadth
43
Persistence
39
Relative
59
Risk quality
91
What supports the view
- Relative performance is improving within its parent hierarchy.
What restrains conviction
- Index trend architecture has not delivered a durable upward expansion.
- Breadth remains too narrow or inconsistent for a high-conviction position.
- Constituent persistence remains divided or predominantly negative.
- Positive contribution is concentrated in a small leadership cohort.
This is a weekly research classification, not personal investment advice. Sentiment is reported as an independent confirmation layer and does not alter the technical score.
Trend state and durability
Architecture, persistence and constituent regimes
The index path is tested against the underlying security-level trend evidence.
Directional pressure is compressed and neither side has durable control.
State age4 weeks
Trend gateMixed
Fan width0.63%
Fast versus slow change-0.99 pts
Above 50%
Below 17%
Six completed weeks of price acceptance relative to the full Activity Line fan.
Index persistence
75% agreement
Positive regime, horizons divided
The 52-week trend is positive, although not every measured horizon confirms it.
13-week
6.2%
26-week
-0.9%
39-week
6.3%
52-week
7.1%
Constituent trend persistence
100% coverage
Is the index move broadly durable?
38%positive
Coherent positive23%
Coherent negative38%
Average horizon agreement83%
Positive horizon share44%
Weakening positives2
Repairing negatives3
13 constituents measured as of 14 Aug 2026. Median trend age is 28 weeks.
Custom stage map
Where constituents sit in the cycle
Stage Analysis coverage is still building.
Capital rotation
Performance relative to Healthcare
Relative index
13-week relative trend
Starting level
A rising relative line means this group is compounding faster than Healthcare. A falling line means capital has done better in the parent benchmark.
Relative index103.6
13-week trend102.7
4-week trend change0.77%
Weekly peer rank3 of 5
1 week
0.2 pts
relative
4 weeks
1.4 pts
relative
13 weeks
3.2 pts
relative
26 weeks
3.8 pts
relative
52 weeks
6.4 pts
relative
Market internals
Participation, dispersion and path risk
Equal-weight index evidence with constituent-level breadth and dispersion.
Breadth
Narrow
Participation quality
38%
advanced
- Advancing
- 5
- Declining
- 8
- Unchanged
- 0
Risk and persistence
52-week lens
Path quality
Annualised weekly volatility15.5%
Drawdown from 52-week high-3.5%
Positive weeks, last 1354%
Current directional run2 weeks
Turnover versus 13-week norm93%
Breadth impulse-9.0 pts
Cross-section
13 measured
Return distribution
Q1 -2.4%
Median -0.8%
Q3 0.9%
Average winner5.2%
Average loser-2.5%
Dispersion6.3 pts
Top-five upside share100%
Top-five capital share94%
Capital data coverage100%
Dispersion describes how far constituent outcomes are spreading apart. Capital concentration is contextual only; the index itself is equal weighted.
Momentum cycle
30-week persistence
Positive readings show expansion. Negative readings show contraction.
Breadth cycle
Net participation
Advancers less decliners as a percentage of measured constituents.
News and narrative
Does company news confirm the market tape?
Sentiment evidence is still developing
Qualified company-level news coverage is not yet broad enough to influence the group view.
0 qualified records across 13 measured constituents.Leadership tape
Leaders, laggards and contribution shape
Latest completed week, ranked on uncapped constituent returns.
Constituent ledger
Industry constituents
All 13 measured constituents, ranked by latest weekly return.
Rank
Ticker
Company
Exchange
Market cap
Close
Index contribution
Return
The index uses capped equal-weight weekly constituent returns. The ledger shows uncapped security returns so outliers remain visible for research.